Identification and drug-induced reversion of molecular signatures of Alzheimer's disease onset and progression in App, App, and 3xTg-AD mouse models.

Background: In spite of many years of research, our understanding of the molecular bases of Alzheimer's disease (AD) is still incomplete, and the medical treatments available mainly target the disease symptoms and are hardly effective. Indeed, the modulation of a single target (e.g.